The Incretin Axis in Cardiovascular Disease

被引：14
作者：
Plutzky, Jorge [1 ]
机构：
[1] Vasc Dis Prevent Program, Boston, MA 02115 USA
来源：
CIRCULATION | 2011年 / 124卷 / 21期
关键词：
Editorials; diabetes mellitus; type; 2; glucose; incretins; inflammation; obesity; GLUCAGON-LIKE PEPTIDE-1; TYPE-2; DIABETES-MELLITUS; GLYCEMIC CONTROL; MYOCARDIAL-INFARCTION; RECEPTOR AGONIST; BIOLOGY; GLP-1; INHIBITION; GLUCOSE; INFLAMMATION;
D O I：
10.1161/CIRCULATIONAHA.111.064139
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2285 / 2289
页数：5
相关论文
共 31 条
[1]   Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4 [J].
Arakawa, Masayuki ;
Mita, Tomoya ;
Azuma, Kosuke ;
Ebato, Chie ;
Goto, Hiromasa ;
Nomiyama, Takashi ;
Fujitani, Yoshio ;
Hirose, Takahisa ;
Kawamori, Ryuzo ;
Watada, Hirotaka .
DIABETES, 2010, 59 (04) :1030-1037
[2]   Adipocyte metabolism and obesity [J].
Attie, Alan D. ;
Scherer, Philipp E. .
JOURNAL OF LIPID RESEARCH, 2009, 50 :S395-S399
[3]   Biology of incretins: GLP-1 and GIP [J].
Baggio, Laurie L. ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2007, 132 (06) :2131-2157
[4]   Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor [J].
Ban, Kiwon ;
Kim, Kyoung-Han ;
Cho, Chan-Kyung ;
Sauve, Meghan ;
Diamandis, Eleftherios P. ;
Backx, Peter H. ;
Drucker, Daniel J. ;
Husain, Mansoor .
ENDOCRINOLOGY, 2010, 151 (04) :1520-1531
[5]   GLP-1 and energy balance: an integrated model of short-term and long-term control [J].
Barrera, Jason G. ;
Sandoval, Darleen A. ;
D'Alessio, David A. ;
Seeley, Randy J. .
NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (09) :507-516
[6]   Adiposopathy Is "Sick Fat" a Cardiovascular Disease? [J].
Bays, Harold E. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (25) :2461-2473
[7]   On the regulatory role of dipeptidyl peptidase IV (=CD26=adenosine deaminase complexing protein) on adenosine deaminase activity [J].
Ben-Shooshan, I ;
Kessel, A ;
Ben-Tal, N ;
Cohen-Luria, R ;
Parola, AH .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (01) :21-30
[8]   Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies A retrospective analysis of the LifeLink database [J].
Best, Jennie H. ;
Hoogwerf, Byron J. ;
Herman, William H. ;
Pelletier, Elise M. ;
Smith, Daniel B. ;
Wenten, Made ;
Hussein, Mohamed A. .
DIABETES CARE, 2011, 34 (01) :90-95
[9]   Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1 [J].
Brubaker, Patricia L. .
ENDOCRINOLOGY, 2010, 151 (05) :1984-1989
[10]   Metabolic and digestive response to food ingestion in a binge-feeding lizard, the Gila monster (Heloderma suspectum) [J].
Christel, C. M. ;
DeNardo, D. F. ;
Secor, S. M. .
JOURNAL OF EXPERIMENTAL BIOLOGY, 2007, 210 (19) :3430-3439
1234